Thyroid-stimulating hormone, thyroid hormones, and bone loss.
It has become accepted by virtue of rich anecdotal experience and clinical research that thyrotoxicosis is associated with high-turnover osteoporosis. The bone loss, primarily due to accelerated resorption that is not compensated by a coupled increase in bone formation, has been attributed solely to elevated thyroid hormone levels. Evidence using mice lacking the thyroid hormone receptors alpha and beta establishes a role for thyroid hormones in regulating bone remodeling but does not exclude an independent action of thyroid-stimulating hormone (TSH), levels of which are low in hyperthyroid states, even when thyroid hormones are normal, as after thyroxine supplementation and in subclinical hyperthyroidism. We show that TSH directly suppresses bone remodeling and that TSH receptor null mice have profound bone loss, suggesting that reduced TSH signaling contributes to hyperthyroid osteoporosis. TSH and its receptor could become valuable drug targets in treating bone loss.
Zaidi
Mone
M
Mount Sinai Bone Program, Mount Sinai School of Medicine, New York, NY 10029, USA. mone.zaidi@mssm.edu
Davies
Terry F
TF
Zallone
Alberta
A
Blair
Harry C
HC
Iqbal
Jameel
J
Moonga
Surinder S
SS
Mechanick
Jeffrey
J
Sun
Li
L
D000818:Animals; D006801:Humans; D006980:Hyperthyroidism / Q000503:physiopathology; D051379:Mice; D023421:Models, Animal; D010012:Osteogenesis / Q000502:physiology; D010024:Osteoporosis / Q000503:physiopathology*; D013963:Thyroid Hormones / Q000502:physiology*; D013971:Thyrotoxicosis / Q000503:physiopathology; D013972:Thyrotropin / Q000502:physiology*
D013963:Thyroid Hormones; D013972:Thyrotropin